Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$533M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Micron Technology
MU
|
+$272M |
| 4 |
Eli Lilly
LLY
|
+$232M |
| 5 |
Super Micro Computer
SMCI
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
NVIDIA
NVDA
|
+$413M |
| 3 |
Tesla
TSLA
|
+$403M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Johnson & Johnson
JNJ
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Industrials | 9.63% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
AYTU BioPharma
AYTU
$24.6M
| $176K | ﹤0.01% |
74,723
+600
| +0.8% | +$1.55K |
|
3152
Hyperfine
HYPR
$97.8M
| $173K | ﹤0.01% |
159,800
+100,400
| +169% | +$107K |
|
3153
NanoViricides
NNVC
$36.5M
| $172K | ﹤0.01% |
114,900
+12,800
| +13% | +$23.8K |
|
3154
Idaho Strategic Resources
IDR
$526M
| $172K | ﹤0.01% |
10,700
-50,050
| -82% | -$599K |
|
3155
DocGo
DCGO
$61.8M
| $170K | ﹤0.01% |
+51,300
| New | +$174K |
|
3156
Achieve Life Sciences
ACHV
$683M
| $170K | ﹤0.01% |
35,860
+10,800
| +43% | +$49.3K |
|
3157
Laureate Education
LAUR
$5.24B
| $169K | ﹤0.01% |
10,200
-320,200
| -97% | -$4.89M |
|
|
AXIA.PR
3158
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
| $169K | ﹤0.01% |
+27,025
| New | +$168K |
|
3159
Surrozen
SRZN
$254M
| $166K | ﹤0.01% |
13,826
+1,400
| +11% | +$12.4K |
|
3160
Immunome
IMNM
$2.89B
| $165K | ﹤0.01% |
11,300
-82,000
| -88% | -$1.17M |
|
3161
Celcuity
CELC
$4.53B
| $165K | ﹤0.01% |
11,045
-40,511
| -79% | -$668K |
|
3162
Escalade
ESCA
$307M
| $164K | ﹤0.01% |
11,630
-600
| -5% | -$8.26K |
|
3163
Sky Harbour Group
SKYH
$381M
| $163K | ﹤0.01% |
+14,800
| New | +$158K |
|
3164
Forafric Global
AFRI
$283M
| $163K | ﹤0.01% |
14,400
-1,254
| -8% | -$13.9K |
|
|
AHG
3165
Akso Health Group
AHG
$1.25B
| $163K | ﹤0.01% |
152,598
-14,662
| -9% | -$14.8K |
|
|
YARW
3166
Yarrow Bioscience, Inc. Common Stock
YARW
$25.2M
| $163K | ﹤0.01% |
1,733
+471
| +37% | +$44.6K |
|
|
SACH
3167
Sachem Capital Corp
SACH
$39.9M
| $161K | ﹤0.01% |
63,900
+52,300
| +451% | +$132K |
|
|
BCOW
3168
DELISTED
1895 Bancorp of Wisconsin
BCOW
| $161K | ﹤0.01% |
+15,900
| New | +$140K |
|
3169
Research Frontiers
REFR
$16.2M
| $160K | ﹤0.01% |
73,100
-10,700
| -13% | -$22.1K |
|
3170
One Stop Systems
OSS
$325M
| $160K | ﹤0.01% |
66,900
+5,700
| +9% | +$12.6K |
|
3171
Verastem
VSTM
$518M
| $159K | ﹤0.01% |
+53,100
| New | +$144K |
|
3172
Fractyl Health
GUTS
$110M
| $159K | ﹤0.01% |
62,695
+48,495
| +342% | +$158K |
|
|
VIGL
3173
DELISTED
Vigil Neuroscience
VIGL
| $156K | ﹤0.01% |
46,000
-25,500
| -36% | -$94.5K |
|
3174
Skillful Craftsman
EDTK
$15.1M
| $156K | ﹤0.01% |
136,900
-5,600
| -4% | -$6.22K |
|
|
SCNX
3175
Scienture Holdings
SCNX
$15.8M
| $155K | ﹤0.01% |
20,500
+8,800
| +75% | +$89.7K |
|
Similar funds
Renaissance Technologies's Q3 2024 Portfolio in Review
As of Q3 2024, Renaissance Technologies held 4,024 positions worth $66.5B, up 13% from $59B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $3.2B of net new capital in Q3 2024, opening 578 new positions and adding to 1,558 existing holdings. Its largest new stake was Micron Technology: 2,604,914 shares worth $270M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $413M trimmed.
- Renaissance Technologies's largest Q3 2024 buy was Micron Technology: 2,604,914 shares worth $270M.
- Renaissance Technologies added most to Microsoft in Q3 2024, an estimated $533M increase.
- Renaissance Technologies's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $413M.
- Renaissance Technologies fully exited Broadcom in Q3 2024, selling an estimated $472M.
- Renaissance Technologies's ten largest holdings make up 11% of its $66.5B portfolio in Q3 2024.
- Renaissance Technologies opened 578 new positions and closed 539 in Q3 2024.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $66.5B.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.